Cardiovascular dysfunction associated with tyrosine kinase inhibitor use in patients with metastatic thyroid cancer

Back

HFA Premium Access

Cardiovascular dysfunction associated with tyrosine kinase inhibitor use in patients with metastatic thyroid cancer

Session: Rapid Fire 6 - Risk stratification and prognosis

Topic: Cardio-Oncology

Speaker: Doctor B. Dowsing (London, GB)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Benjamin Dowsing

University College London, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

14 more presentations in this session

Machine learning based risk stratification of patients undergoing cardiac resynchronization therapy

Speaker: Doctor M. Tokodi (Budapest, HU)

Prognostic impact of ICD interventions in a real-world primary and secondary prevention population

Speaker: Assistant Professor M. Canepa (Genoa, IT)

Predicting arrhythmic risk in dilated cardiomyopathy: a meta-analysis of clinical parameter

Speaker: Doctor A. Sammani (Utrecht, NL)

Serial change of Layer-specific myocardial functionby Chemotherapy in Breast cancer patients

Speaker: Doctor M. Kim (Seoul, KR)

Forecast of mOrtality Risk Early in the postCardiac Arrest Syndrome Therapy: pilot score for estimate early mortality in post cardiac arrest syndrome patient population

Speaker: Associate Professor E. Zima (Budapest, HU)

Access the full session

Rapid Fire 6 - Risk stratification and prognosis

Speakers: Doctor B. Dowsing, Doctor M. Tokodi, Assistant Professor M. Canepa, Doctor A. Sammani, Doctor M. Kim...

Access

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources